Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECMOxy: Normoxemia vs Hyperoxemia in VA-ECMO
NCT04990349Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- Jan 2022
- Primary completion
- Nov 2023
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of oxygen in cardiogenic shock, sponsored by CHU de Besançon. Started Jan 2022; status: completed.
02
Drugs
oxygen
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT04990349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04990349.